A retrospective analysis conducted at a single center examined clinical and demographic variations in children hospitalized for Epstein–Barr virus (EBV) infection across three distinct time intervals spanning 2018 to 2025. These periods were selected to broadly align with the different phases of the COVID-19 pandemic. The researchers identified measurable temporal shifts in patient age, specific laboratory markers, and infection status classifications among the study population, though these observations reflect the specific cohort of hospitalized cases rather than epidemiological changes in the broader general pediatric population.
The study encompassed 442 children hospitalized with EBV infection, categorized into three intervals: 2018–2019 (39 cases), 2020–2022 (96 cases), and 2023–2025 (307 cases). This distribution highlights a marked imbalance in sample size between periods. Annual case counts demonstrated significant fluctuation, with 4 recorded in 2018, 35 in 2019, 2 in 2020, 21 in 2021, 73 in 2022, and 117, 119, and 71 cases in 2023, 2024, and 2025, respectively. The investigators clarified that this temporal classification served to describe period-specific clinical and laboratory differences, explicitly stating that the data was not intended to establish a causal relationship between the COVID-19 pandemic or related public health measures and EBV infection rates.
The researchers observed statistically significant shifts in age distribution across the study periods (χ² = 20.07, P < 0.001), characterized by a larger proportion of older children during the 2023–2025 interval compared to the earlier windows.
Variability was also identified in key laboratory parameters. EBV nuclear antigen antibody levels and viral capsid antigen IgG levels were significantly higher during the 2020–2022 period than in the other analyzed intervals. Conversely, plasma EBV-DNA levels were found to be lower during this middle period.
The assessment of clinical outcomes indicated a nominal period difference regarding non-severe pneumonia (P = 0.046); however, the statistical analysis did not detect significant differences between periods for the other clinical outcomes evaluated in the study. The researchers noted that infection-status classification was available for 267 children, and the completeness of this data varied substantially between the three time periods, which influences the interpretation of these findings.
Documented coinfection occurred in 206 children, accounting for 46.61% of the analyzed cohort. When the investigators assessed the association between coinfection and clinical complications, they observed that coinfection was linked to increased odds of both non-severe pneumonia (OR = 2.63, 95% CI: 1.79–3.87) and severe pneumonia (OR = 5.23, 95% CI: 1.47–18.62). Interestingly, these cases exhibited lower odds of liver function impairment (OR = 0.31, 95% CI: 0.15–0.68), providing a detailed picture of the complex comorbidities present in this hospitalized population.
Economic data included in the review indicated that hospital resource utilization, measured via hospitalization costs, was higher during the final period of 2023–2025.
The study concludes that temporal differences are present in the demographic and clinical profiles of hospitalized children with EBV infection. While a lower proportion of acute primary infection was noted in 2020–2022 compared to 2023–2025, the authors recommended interpreting this finding with caution due to the noted differences in the completeness of infection-status classification across the periods. The researchers emphasized that their findings reflect the period-specific characteristics of hospitalized children and should not be interpreted as evidence of broader shifts in EBV epidemiology in the general pediatric population.
Subject of Research: Clinical characteristics of hospitalized children with Epstein–Barr virus infection
Article Title: Period-specific differences in clinical characteristics of hospitalized children with Epstein–Barr virus infection: a single-center retrospective study
Article References: Zhang, Z., Zhan, T., Hu, J., & Zhang, J. (2026). Period-specific differences in clinical characteristics of hospitalized children with Epstein–Barr virus infection: a single-center retrospective study. BMC Infectious Diseases. https://doi.org/10.1186/s12879-026-14627-2
Image Credits: AI Generated
DOI: 10.1186/s12879-026-14627-2
Keywords: Epstein-Barr virus, pediatric infectious disease, hospital-based retrospective study, clinical characteristics, viral infection, COVID-19 pandemic period, patient demographics, laboratory parameters, disease complications, viral capsid antigen, non-severe pneumonia, severe pneumonia, liver function impairment, temporal changes, pediatric hospitalization, EBV-DNA, infection status, comorbidities
News Source: Kristina Jarvis. (November 18, 2026). Hospitalized Children with EBV Show Temporal Differences in Clinical Characteristics. Scienmag.



